health care cost

Research in Review
Decreasing TKI Dosage Provides Better Outcomes in CML, Lowers Costs
06/29/2017
JCP Editors
Patients with chronic myeloid leukemia (CML) who receive half the standard dose of tyrosine kinase inhibitor (TKI) therapy are likely to eliminate most adverse events, drastically reduce costs, and improve...
Patients with chronic myeloid leukemia (CML) who receive half the standard dose of tyrosine kinase inhibitor (TKI) therapy are likely to eliminate most adverse events, drastically reduce costs, and improve...
...
06/29/2017
Journal of Clinical Pathways
Research in Review
High Cost of Care for Older Patients With Brain Tumors at EOL
06/23/2017
JCP Editors
Hospital-based end-of-life (EOL) care for older patients with malignant brain tumors is associated with over $16,000 in expenses per patient, according to a research letter published in JAMA Oncology (published...
Hospital-based end-of-life (EOL) care for older patients with malignant brain tumors is associated with over $16,000 in expenses per patient, according to a research letter published in JAMA Oncology (published...
...
06/23/2017
Journal of Clinical Pathways
Interview
Estimating Real Costs of Care for Different Cancers, Insurance Types
06/12/2017
JCP Editors
A report from the American Cancer Society Cancer Action Network (ACS CAN) estimated the total costs to patients associated with cancer diagnoses and treatment, based on their type of insurance. ----- Related...
A report from the American Cancer Society Cancer Action Network (ACS CAN) estimated the total costs to patients associated with cancer diagnoses and treatment, based on their type of insurance. ----- Related...
A...
06/12/2017
Journal of Clinical Pathways
Research in Review
B-Cell Malignancy Provides Economic Burden to US Commercial Payers
05/30/2017
JCP Editors
The high economic burden of B-cell malignancies on US commercial insurers may impact future reimbursement decisions, according to research that will be presented at the 2017 ASCO Annual Meeting (June 2-6, 2017;...
The high economic burden of B-cell malignancies on US commercial insurers may impact future reimbursement decisions, according to research that will be presented at the 2017 ASCO Annual Meeting (June 2-6, 2017;...
The...
05/30/2017
Journal of Clinical Pathways
Department
Cancer Patients Unfamiliar With Clinical Practice Guidelines, Clinical Pathways
04/12/2017
JCP Editors
Results of a recent survey of the cancer care experience revealed barriers to navigating cancer care, including high costs and lack of information about how treatment decisions are made. ----- Related...
Results of a recent survey of the cancer care experience revealed barriers to navigating cancer care, including high costs and lack of information about how treatment decisions are made. ----- Related...
...
04/12/2017
Journal of Clinical Pathways
Department
Colon Cancer Costs Continue Rising
03/15/2017
JCP Editors
The cost of colon cancer care rose significantly during the period from 2003 to 2013, despite decreases in overall hospitalizations and lengths of stay. ----- Related Content Adjuvant Chemotherapy Improves Colon...
The cost of colon cancer care rose significantly during the period from 2003 to 2013, despite decreases in overall hospitalizations and lengths of stay. ----- Related Content Adjuvant Chemotherapy Improves Colon...
The...
03/15/2017
Journal of Clinical Pathways
Research in Review
COST Tool Measures Financial Toxicity of Patient Cancer Treatment
10/14/2016
JCP Editors
Cancer and its treatments lead to financial toxicity for patients, according to cancer specialists who reported the findings from using the Comprehensive Score for Financial Toxicity (COST) questionnaire in Cancer....
Cancer and its treatments lead to financial toxicity for patients, according to cancer specialists who reported the findings from using the Comprehensive Score for Financial Toxicity (COST) questionnaire in Cancer....
Cancer...
10/14/2016
Journal of Clinical Pathways
Research in Review
Study Identifies Financial Ties Among NCCN Guideline Authors and Drug Industry
09/02/2016
JCP Editors
A new study that quantifies industry financial conflicts of interest (FCOIs) found that nearly nine out of 10 physicians and researchers who helped develop the National Comprehensive Network (NCCN) guidelines—work...
A new study that quantifies industry financial conflicts of interest (FCOIs) found that nearly nine out of 10 physicians and researchers who helped develop the National Comprehensive Network (NCCN) guidelines—work...
A new...
09/02/2016
Journal of Clinical Pathways
Research in Review
Value for US Cancer Drug Spending Lags Behind Other Nations
05/03/2016
JCP Editors
A study of international cancer care costs has revealed that the value of US cancer drug spending has not kept pace with that of other nations in terms of health gains per dollar spent. Sebastian Salas-Vega, MSc,...
A study of international cancer care costs has revealed that the value of US cancer drug spending has not kept pace with that of other nations in terms of health gains per dollar spent. Sebastian Salas-Vega, MSc,...
A...
05/03/2016
Journal of Clinical Pathways
Revealing Treatment Costs at the Point of Care Beneficial to Patients and Providers
03/08/2016
JCP Editors
A tool integrating costs associated with common cancer treatments with electronic medical records was beneficial to both physicians and patients, according to results of a study presented at the conference. Patients...
A tool integrating costs associated with common cancer treatments with electronic medical records was beneficial to both physicians and patients, according to results of a study presented at the conference. Patients...
A tool...
03/08/2016
Journal of Clinical Pathways

Upcoming Events

February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
SAWC Spring
April 30 ⁠–⁠ May 4
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
WoundCon
May 1 ⁠–⁠ May 3
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use